Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chantévy Pou"'
Publikováno v:
Biosensors, Vol 11, Iss 2, p 42 (2021)
Circulating tumour DNA (ctDNA) is widely used in liquid biopsies due to having a presence in the blood that is typically in proportion to the stage of the cancer and because it may present a quick and practical method of capturing tumour heterogeneit
Externí odkaz:
https://doaj.org/article/42033722bfba4c4e938cf34ac6fcf585
Autor:
Bukola Attoye, Chantevy Pou, Ewen Blair, Christopher Rinaldi, Fiona Thomson, Matthew J. Baker, Damion K. Corrigan
Publikováno v:
Biosensors, Vol 10, Iss 11, p 156 (2020)
It is well-known that two major issues, preventing improved outcomes from cancer are late diagnosis and the evolution of drug resistance during chemotherapy, therefore technologies that address these issues can have a transformative effect on healthc
Externí odkaz:
https://doaj.org/article/904c7b8fb1534c46aec16b5a99ea04fc
Autor:
Sultan Ahmad, Dajan O'Donnell, Kemal Payza, Chantévy Pou, Huy K. Vu, Paola AstraZeneca R D Montreal St. Laurent Lembo, Philippe Walker, Claude Godbout, Andrea Jakob, Jack AstraZeneca R D Montreal Cao, Manon Pelletier
Publikováno v:
The Journal of biological chemistry. 273(48)
A cDNA encoding a thyrotropin-releasing hormone (TRH) receptor expressed in the pituitary was previously cloned (De La Pena, P., Delgado, L. M., Del Camino, D., and Barros, F. (1992) Biochem. J. 284, 891-899; De La Pena, P., Delgado, L. M., Del Camin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ea15b7870c3eee4e9a3ee9225d8a0d
https://pubmed.ncbi.nlm.nih.gov/9822707
https://pubmed.ncbi.nlm.nih.gov/9822707